Alnylam Pharmaceuticals, Inc. (ALNY)
Cambridge, MA
Total Compensation for Fiscal Year Ending in 2024: $11,492,970
| Salary | $1,253,400 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $3,625,000 |
| Value of Option Awards | $3,614,400 |
| Non-Equity Incentive Plan Compensation | $2,975,400 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $24,770 |
| Total | $11,492,970 |
Alnylam Pharmaceuticals, Inc. disclosed its CEO pay was
39
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?
